Riskpilot← Back to searchSign inGet full accessNordic BioSite JVE AB
ABDissolvedOrg 5591938823Economic activity was not specified by tax authority · NACE 0000Est. 20190 employees
Revenue 2022
SEK 0
EBITDA margin
—
+157% vs 2021
Equity ratio
100.0%
Financial strength
Net profit 2022
SEK -979K
-2231% vs 2021
| Revenue | SEK 0 | — |
| EBITDA | SEK 24K | +157% |
| Net profit | SEK -979K | -2231% |
| Total assets | SEK 75K | -93% |
| Equity | SEK 75K | -93% |
| Employees | 0 | — |
Legal name
Nordic BioSite JVE AB
Org number
5591938823
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
6 februari 2019
Share capital
SEK 107 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanterna
Company purpose
Bolaget ska äga och förvalta fast och lös egendom samt idka därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — |
| EBITDA | −1 | −20 | −42 | 24 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | −1 | −20 | −42 | 24 |
| Net financials | — | — | — | −2 004 |
| Profit before tax | −1 | −20 | −42 | −979 |
| Tax | −0 | −0 | −0 | −0 |
| Net profit | −1 | −20 | −42 | −979 |
| Item | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| Total assets | 1 121 | 1 110 | 1 094 | 75 |
| Equity | 1 067 | 1 046 | 1 004 | 75 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 54 | 63 | 90 | 0 |
| Total debt | 54 | 63 | 90 | — |
EBITDA margin
2400000.0%
This company
15.8%
Market median
+15189773% vs market
20192022
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20192022
Return on equity
-1305.3%
This company
18.4%
Market median
-7194% vs market
20192022
Net profit margin
-97900000.0%
This company
8.1%
Market median
-1208642075% vs market
20192022
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192022
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20192022
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-02-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
CO | Audit | 2020 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Deputy Board Member | 2023 | |
| Deputy Board Member | 2023 | |
| Board of Directors | 2023 | |
| Deputy Board Member | 2023 | |
| Former (4) | ||
| Deputy Board Member | 2022 – 2023 | |
| Chairman | 2020 – 2021 | |
| Chairman | 2021 – 2022 | |
| Deputy Board Member | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Europa Biosite Group ABEuropa Biosite Holding ABNordic Biosite AB
Nordic BioSite JVE AB (this company)Board members of Nordic BioSite JVE AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Claes Olof Thore Sjödin | Audit | 0 companies |
| Lena Birgitta Killgren Jonsson | Deputy Board Member | 0 companies |
| Inger Margareta Dahle | Deputy Board Member | 0 companies |
| Bengt Junior Niklas Nygårds | Board of Directors | 0 companies |
| Lars Olof Erhard Gisterå | Deputy Board Member | 0 companies |
| Yvonne Diana Zar | Chairman | 0 companies |
| Ulrika Margareta Ahlholm | Deputy Board Member | 0 companies |
| Wilhelmus Catharina Martinus van Hamond | Chairman | 0 companies |
| Kunal Pandit | Deputy Board Member | 0 companies |